Genetics of the neuronal ceroid lipofuscinoses (Batten disease)

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 10, 2015, Pages 2237-2241

  Mole, Sara E ^a,b   Cotman, Susan L ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Batten; CLN; Genetics; Mutation; NCL; Neuronal ceroid lipofuscinosis

Indexed keywords

CYTOPLASM PROTEIN; LYSOSOME ENZYME; MEMBRANE PROTEIN;

GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; NEURONAL CEROID LIPOFUSCINOSIS; PRIORITY JOURNAL; REVIEW;

EID: 84940790003     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2015.05.011     Document Type: Review

References (39)

1. Noskova L., Stranecky V., Hartmannova H., Pristoupilova A., Baresova V., Ivanek R., Hulkova H., Jahnova H., van der Zee J., Staropoli J.F., Sims K.B., Tyynela J., Van Broeckhoven C., Nijssen P.C., Mole S.E., Elleder M., Kmoch S. Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis. Am. J. Hum. Genet. 2011, 89:241-252.
2. Vantaggiato C., Redaelli F., Falcone S., Perrotta C., Tonelli A., Bondioni S., Morbin M., Riva D., Saletti V., Bonaglia M.C., Giorda R., Bresolin N., Clementi E., Bassi M.T. A novel CLN8 mutation in late-infantile-onset neuronal ceroid lipofuscinosis (LINCL) reveals aspects of CLN8 neurobiological function. Hum. Mutat. 2009, 30:1104-1116.
3. Ryan C.L., Baranowski D.C., Chitramuthu B.P., Malik S., Li Z., Cao M., Minotti S., Durham H.D., Kay D.G., Shaw C.A., Bennett H.P., Bateman A. Progranulin is expressed within motor neurons and promotes neuronal cell survival. BMC Neurosci. 2009, 10:130.
4. Neverman N.J., Best H.L., Hofmann S.L., Hughes S.M. Experimental Therapies in the Neuronal Ceroid Lipofuscinoses. Biochim. Biophys. Acta 2015, 1852:2292-2300.
5. Cárcel-Trullols J., Kovács A.D., Pearce D.A. Cell biology of the NCL proteins: what they do and don't do. Biochim. Biophys. Acta 2015, 1852:2242-2255.
6. Arsov T., Smith K.R., Damiano J., Franceschetti S., Canafoglia L., Bromhead C.J., Andermann E., Vears D.F., Cossette P., Rajagopalan S., McDougall A., Sofia V., Farrell M., Aguglia U., Zini A., Meletti S., Morbin M., Mullen S., Andermann F., Mole S.E., Bahlo M., Berkovic S.F. Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6. Am. J. Hum. Genet. 2011, 88:566-573.
7. Williams R.E., Mole S.E. New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses. Neurology 2012, 79:183-191.
8. Ranta S., Zhang Y., Ross B., Lonka L., Takkunen E., Messer A., Sharp J., Wheeler R., Kusumi K., Mole S., Liu W., Soares M.B., de Fatima Bonaldo M., Hirvasniemi A., de la Chapelle A., Gilliam T.C., Lehesjoki A.E. The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nat. Genet. 1999, 23:233-236.
9. Sun Y., Almomani R., Breedveld G.J., Santen G.W., Aten E., Lefeber D.J., Hoff J.I., Brusse E., Verheijen F.W., Verdijk R.M., Kriek M., Oostra B., Breuning M.H., Losekoot M., den Dunnen J.T., van de Warrenburg B.P., Maat-Kievit A.J. Autosomal recessive spinocerebellar ataxia 7 (SCAR7) is caused by variants in TPP1, the gene involved in classic late-infantile neuronal ceroid lipofuscinosis 2 disease (CLN2 disease). Hum. Mutat. 2013, 34:706-713.
10. Smith K.R., Damiano J., Franceschetti S., Carpenter S., Canafoglia L., Morbin M., Rossi G., Pareyson D., Mole S.E., Staropoli J.F., Sims K.B., Lewis J., Lin W.L., Dickson D.W., Dahl H.H., Bahlo M., Berkovic S.F. Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. Am. J. Hum. Genet. 2012, 90:1102-1107.
11. Erickson R.P., Larson-Thome K., Weberg L., Szybinska A., Mossakowska M., Styczynska M., Barcikowska M., Kuznicki J. Variation in NPC1, the gene encoding Niemann-Pick C1, a protein involved in intracellular cholesterol transport, is associated with Alzheimer disease and/or aging in the Polish population. Neurosci. Lett. 2008, 447:153-157.
12. Aharon-Peretz J., Rosenbaum H., Gershoni-Baruch R. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med. 2004, 351:1972-1977.
13. Kitzmüller C., Haines R., Codlin S., Cutler D.F., Mole S.E. A function retained by the common mutant CLN3 protein is responsible for the late onset of juvenile neuronal ceroid lipofuscinosis (JNCL). Hum. Mol. Genet. 2008, 17:303-312.
14. Wang F., Wang H., Tuan H.F., Nguyen D.H., Sun V., Keser V., Bowne S.J., Sullivan L.S., Luo H., Zhao L., Wang X., Zaneveld J.E., Salvo J.S., Siddiqui S., Mao L., Wheaton D.K., Birch D.G., Branham K.E., Heckenlively J.R., Wen C., Flagg K., Ferreyra H., Pei J., Khan A., Ren H., Wang K., Lopez I., Qamar R., Zenteno J.C., Ayala-Ramirez R., Buentello-Volante B., Fu Q., Simpson D.A., Li Y., Sui R., Silvestri G., Daiger S.P., Koenekoop R.K., Zhang K., Chen R. Next generation sequencing-based molecular diagnosis of retinitis pigmentosa: identification of a novel genotype-phenotype correlation and clinical refinements. Hum. Genet. 2013, 133:331-345.
15. Cortese A., Tucci A., Piccolo G., Galimberti C.A., Fratta P., Marchioni E., Grampa G., Cereda C., Grieco G., Ricca I., Pittman A., Ciscato P., Napoli L., Lucchini V., Ripolone M., Violano R., Fagiolari G., Mole S.E., Hardy J., Moglia A., Moggio M. Novel CLN3 mutation causing autophagic vacuolar myopathy. Neurology 2014, 82:2072-2076.
16. Roosing S., van den Born L.I., Sangermano R., Banfi S., Koenekoop R.K., Zonneveld-Vrieling M.N., Klaver C.C., van Lith-Verhoeven J.J., Cremers F.P., den Hollander A.I., Hoyng C.B. Mutations in MFSD8, encoding a lysosomal membrane protein, are associated with monsyndromic autosomal recessive macular dystrophy. Ophthalmology 2015, 122:170-179.
17. Staropoli J.F., Karaa A., Lim E.T., Kirby A., Elbalalesy N., Romansky S.G., Leydiker K.B., Coppel S.H., Barone R., Xin W., Macdonald M.E., Abdenur J.E., Daly M.J., Sims K.B., Cotman S.L. A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin-proteasome system. Am. J. Hum. Genet. 2012, 91:202-208.
18. Blumkin L., Kivity S., Lev D., Cohen S., Shomrat R., Lerman-Sagie T., Leshinsky-Silver E. A compound heterozygous missense mutation and a large deletion in the KCTD7 gene presenting as an opsoclonus-myoclonus ataxia-like syndrome. J. Neurol. 2012, 259:2590-2598.
19. Van Bogaert P., Azizieh R., Desir J., Aeby A., De Meirleir L., Laes J.F., Christiaens F., Abramowicz M.J. Mutation of a potassium channel-related gene in progressive myoclonic epilepsy. Ann. Neurol. 2007, 61:579-586.
20. Kousi M., Anttila V., Schulz A., Calafato S., Jakkula E., Riesch E., Myllykangas L., Kalimo H., Topcu M., Gokben S., Alehan F., Lemke J.R., Alber M., Palotie A., Kopra O., Lehesjoki A.E. Novel mutations consolidate KCTD7 as a progressive myoclonus epilepsy gene. J. Med. Genet. 2012, 49:391-399.
21. Bras J., Verloes A., Schneider S.A., Mole S.E., Guerreiro R.J. Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis. Hum. Mol. Genet. 2012, 21:2646-2650.
22. Sleat D.E., Ding L., Wang S., Zhao C., Wang Y., Xin W., Zheng H., Moore D.F., Sims K.B., Lobel P. Mass spectrometry-based protein profiling to determine the cause of lysosomal storage diseases of unknown etiology. Mol. Cell. Proteomics 2009, 8:1708-1718.
23. Staropoli J.F., Xin W., Barone R., Cotman S.L., Sims K.B. An atypical case of neuronal ceroid lipofuscinosis with co-inheritance of a variably penetrant POLG1 mutation. BMC Med. Genet. 2012, 13:50.
24. Zhang C.K., Stein P.B., Liu J., Wang Z., Yang R., Cho J.H., Gregersen P.K., Aerts J.M., Zhao H., Pastores G.M., Mistry P.K. Genome-wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation. Am. J. Hematol. 2012, 87:377-383.
25. Forbes S.A., Bindal N., Bamford S., Cole C., Kok C.Y., Beare D., Jia M., Shepherd R., Leung K., Menzies A., Teague J.W., Campbell P.J., Stratton M.R., Futreal P.A. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 2011, 39:D945-D950.
26. Sartelet A., Stauber T., Coppieters W., Ludwig C.F., Fasquelle C., Druet T., Zhang Z., Ahariz N., Cambisano N., Jentsch T.J., Charlier C. A missense mutation accelerating the gating of the lysosomal Cl-/H+-exchanger ClC-7/Ostm1 causes osteopetrosis with gingival hamartomas in cattle. Dis. Model. Mech. 2014, 7:119-128.
27. Mole S.E., Williams R.E., Goebel H.H. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics 2005, 6:107-126.
28. Kousi M., Lehesjoki A.E., Mole S.E. Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses. Hum. Mutat. 2012, 33:42-63.
29. Haddad S.E., Khoury M., Daoud M., Kantar R., Harati H., Mousallem T., Alzate O., Meyer B., Boustany R.M. CLN5 and CLN8 protein association with ceramide synthase: biochemical and proteomic approaches. Electrophoresis 2012, 33:3798-3809.
30. Schulz A., Dhar S., Rylova S., Dbaibo G., Alroy J., Hagel C., Artacho I., Kohlschutter A., Lin S., Boustany R.M. Impaired cell adhesion and apoptosis in a novel CLN9 Batten disease variant. Ann. Neurol. 2004, 56:342-350.
31. Vesa J., Hellsten E., Verkruyse L.A., Camp L.A., Rapola J., Santavuori P., Hofmann S.L., Peltonen L. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 1995, 376:584-587.
32. Sleat D.E., Donnelly R.J., Lackland H., Liu C.-G., Sohar I., Pullarkat R.K., Lobel P. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science 1997, 277:1802-1805.
33. The International Batten Disease Consortium Isolation of a novel gene underlying Batten disease, CLN3. Cell 1995, 82:949-957.
34. Savukoski M., Klockars T., Holmberg V., Santavuori P., Lander E.S., Peltonen L. CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis. Nat. Genet. 1998, 19:286-288.
35. Wheeler R.B., Sharp J.D., Schultz R.A., Joslin J.M., Williams R.E., Mole S.E. The gene mutated in variant late infantile neuronal ceroid lipofuscinosis (CLN6) and nclf mutant mice encodes a novel predicted transmembrane protein. Am. J. Hum. Genet. 2002, 70:537-542.
36. Siintola E., Topcu M., Aula N., Lohi H., Minassian B.A., Paterson A.M., Liu X.-Q., Wilson C., Lahtinen U., Anottonen A.-K., Lehesjoki A.-E. The novel neuronal ceroid lipofusinosis gene MFSD8 encodes a putative lysosomal transporter. Am. J. Hum. Genet. 2007, 81:136-146.
37. Siintola E., Partanen S., Strömme P., Haapanen A., Haltia M., Maehlen J., Lehesjoki A.E., Tyynelä J. Cathepsin D deficiency underlies congenital human neuronal ceroid lipofuscinosis. Brain 2006, 129:1438-1445.
38. Steinfeld R., Reinhardt K., Schreiber K., Hillebrand M., Kraetzner R., Brück W., Saftig P., Gärtner J. Cathepsin D deficiency is associated with a human neurodegenerative disorder. Am. J. Hum. Genet. 2006, 78:988-998.
39. Smith K.R., Dahl H.-H., Canafoglia L., Andermann E., Damiano J., Morbin M., Bruni A.C., Giaccone G., Cossette P., Saftig P., Grötzinger J., Schwake M., Andermann F., Staropoli J.F., Sims K.B., Mole S.E., Franceschetti S., Alexander N.A., Cooper J.D., Chapman H.A., Carpenter S., Berkovic S.F., Bahlo M. Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis. Hum. Mol. Genet. 2013, 22:1417-1423.